
Aprea Therapeutics APRE
€ 0.66
0.62%
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Aprea Therapeutics EV/EBITDA 2011-2026 | APRE
EV/EBITDA Jährlich Aprea Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -248 | -0.547 | -3.18 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.547 | -248 | -84 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
9.24 | $ 3.54 | -0.7 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
-3.79 | $ 3.25 | 3.83 % | $ 229 M | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
-4.34 | $ 4.16 | -1.42 % | $ 105 M | ||
|
Aptorum Group Limited
APM
|
29.4 | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
argenx SE
ARGX
|
-39.4 | $ 712.23 | 1.27 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
-15.7 | $ 228.93 | -0.91 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.39 | -6.09 % | $ 8.16 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
-0.282 | $ 6.15 | 1.57 % | $ 501 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.37 | $ 6.62 | -0.15 % | $ 181 M | ||
|
BioCardia
BCDA
|
-0.747 | $ 1.35 | 6.29 % | $ 28.6 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 3.58 | -0.28 % | $ 7.79 B | ||
|
Catalyst Biosciences
CBIO
|
0.34 | $ 11.29 | -2.51 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
38.7 | $ 14.58 | 1.53 % | $ 214 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
CNS Pharmaceuticals
CNSP
|
0.205 | $ 2.32 | -5.51 % | $ 887 K | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.76 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.92 | $ 2.69 | 1.7 % | $ 16.9 M | ||
|
Curis
CRIS
|
-7.31 | $ 0.89 | 3.74 % | $ 5.61 M | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 93.04 | 2.76 % | $ 27.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.51 | -0.33 % | $ 385 M | ||
|
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M |